首页 | 本学科首页   官方微博 | 高级检索  
     


Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines
Authors:Daniela Schilling  Christine Bayer  Anneke Geurts-Moespot  Fred CGJ Sweep  Martin Pruschy  Karin Mengele  Lisa D Sprague  Michael Molls
Affiliation:1.Department of Radiation Oncology, Klinikum rechts der Isar,Technical University of Munich,Munich,Germany;2.GSF – Institute of Pathology, KKG,Innate Immunity in Tumor Biology,Neuherberg,Germany;3.Department of Chemical Endocrinology,Radboud University Nijmegen Medical Centre,Nijmegen,The Netherlands;4.Department of Radiation Oncology,University Hospital Zürich,Zürich,Switzerland;5.Clinical Research Unit of the Department of Obstetrics and Gynaecology, Klinikum rechts der Isar,Technical University of Munich,München,Germany;6.Institute of Molecular Pathogenesis,Friedrich-Loeffler-Institut,Jena,Germany
Abstract:

Background  

Squamous cell carcinoma of the head and neck (SCCHN) often contain highly radioresistant hypoxic regions, nonetheless, radiotherapy is a common treatment modality for these tumours. Reoxygenation during fractionated radiotherapy is desired to render these hypoxic tumour regions more radiosensitive. Hypoxia additionally leads to up-regulation of PAI-1, a protein involved in tumour progression and an established prognostic marker for poor outcome. However, the impact of reoxygenation and radiation on PAI-1 levels is not yet clear. Therefore, we investigated the kinetics of PAI-1 expression and secretion after hypoxia and reoxygenation, and determined the influence of ionizing radiation on PAI-1 levels in the two human SCCHN cell lines, BHY and FaDu.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号